DRI Healthcare Trust (DHT.UN) Competitors C$14.26 -0.05 (-0.35%) As of 08/22/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesBuy This Stock DHT.UN vs. ATT, AGRA, MJ, BIO, BBM, BAMM, LOVE, CSI, CALI, and DCNNShould you be buying DRI Healthcare Trust stock or one of its competitors? The main competitors of DRI Healthcare Trust include Abattis Bioceuticals (ATT), Agraflora Organics International (AGRA), Amplify Alternative Harvest ETF (MJ), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), BooksAMillion (BAMM), Cannara Biotech (LOVE), Chemesis International (CSI), China Auto Logistics (CALI), and Digicann Ventures (DCNN). These companies are all part of the "drug manufacturers - specialty & generic" industry. DRI Healthcare Trust vs. Its Competitors Abattis Bioceuticals Agraflora Organics International Amplify Alternative Harvest ETF Bio-Rad Laboratories Blueberries Medical BooksAMillion Cannara Biotech Chemesis International China Auto Logistics Digicann Ventures DRI Healthcare Trust (TSE:DHT.UN) and Abattis Bioceuticals (CNSX:ATT) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends. Does the media favor DHT.UN or ATT? In the previous week, DRI Healthcare Trust's average media sentiment score of 1.57 beat Abattis Bioceuticals' score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media. Company Overall Sentiment DRI Healthcare Trust Very Positive Abattis Bioceuticals Neutral Do insiders & institutionals believe in DHT.UN or ATT? 48.4% of DRI Healthcare Trust shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher valuation & earnings, DHT.UN or ATT? DRI Healthcare Trust has higher revenue and earnings than Abattis Bioceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDRI Healthcare TrustC$193.66MN/AC$9.73M-C$0.05-285.20Abattis BioceuticalsN/AN/AN/AN/AN/A Do analysts recommend DHT.UN or ATT? DRI Healthcare Trust currently has a consensus price target of C$19.50, indicating a potential upside of 36.75%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, analysts clearly believe DRI Healthcare Trust is more favorable than Abattis Bioceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DRI Healthcare Trust 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Abattis Bioceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is DHT.UN or ATT more profitable? DRI Healthcare Trust has a net margin of 5.02% compared to Abattis Bioceuticals' net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Abattis Bioceuticals' return on equity.Company Net Margins Return on Equity Return on Assets DRI Healthcare Trust5.02% 2.06% 4.22% Abattis Bioceuticals N/A N/A N/A SummaryDRI Healthcare Trust beats Abattis Bioceuticals on 10 of the 10 factors compared between the two stocks. Get DRI Healthcare Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for DHT.UN and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DHT.UN vs. The Competition Export to ExcelMetricDRI Healthcare TrustDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapN/AC$2.26BC$5.76BC$6.37BDividend Yield3.26%2.92%4.41%6.72%P/E Ratio-285.204.2931.1073.11Price / SalesN/A691.66433.221,702.25Price / CashN/A10.3737.7383.29Price / Book1.5311.959.534.90Net IncomeC$9.73MC$20.70BC$3.26BC$301.20M7 Day Performance0.07%1.17%2.10%1.35%1 Month Performance-3.58%4.45%2.81%1.88%1 Year Performance12.37%3.65%30.56%27.39% DRI Healthcare Trust Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DHT.UNDRI Healthcare Trust2.0691 of 5 starsC$14.26-0.3%C$19.50+36.7%+11.9%C$0.00C$193.66M-285.20N/APositive NewsATTAbattis BioceuticalsN/AN/AN/AN/AC$0.00N/A0.00N/AGap UpAGRAAgraflora Organics InternationalN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeMJAmplify Alternative Harvest ETFN/AN/AN/AN/A$0.00N/A0.007Gap UpBIOBio-Rad LaboratoriesN/AN/AN/AN/A$0.00N/A0.008,000High Trading VolumeBBMBlueberries MedicalN/AN/AN/AN/A$0.00N/A0.008High Trading VolumeBAMMBooksAMillionN/AN/AN/AN/A$0.00N/A0.00142High Trading VolumeLOVECannara BiotechN/AN/AN/AN/A$0.00N/A0.00N/ANews CoverageHigh Trading VolumeCSIChemesis InternationalN/AN/AN/AN/A$0.00N/A0.00147,000Gap DownHigh Trading VolumeCALIChina Auto LogisticsN/AN/AN/AN/A$0.00N/A0.0040Gap DownHigh Trading VolumeDCNNDigicann VenturesN/AN/AN/AN/A$0.00N/A0.00N/A Related Companies and Tools Related Companies Abattis Bioceuticals Competitors Agraflora Organics International Competitors Amplify Alternative Harvest ETF Competitors Bio-Rad Laboratories Competitors Blueberries Medical Competitors BooksAMillion Competitors Cannara Biotech Competitors Chemesis International Competitors China Auto Logistics Competitors Digicann Ventures Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:DHT.UN) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DRI Healthcare Trust Please log in to your account or sign up in order to add this asset to your watchlist. Share DRI Healthcare Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access